![]() |
||||||||||||||||||||||||||||||||||||||||||||
![]() |
Trihexyphenidyl HydrochlorideClass: Anticholinergic Agents Antimuscarinic antiparkinsonian agent.a b Uses for Trihexyphenidyl Hydrochloride Parkinsonian SyndromeAdjunctive treatment of all forms of parkinsonian syndrome.a b May reduce the frequency and duration of oculogyric crises, salivation, spastic contractions, and dyskinesia, and relieve mental inertia and depression characteristic of all forms of parkinsonian syndrome.b Drug-Induced Extrapyramidal ReactionsControl of extrapyramidal reactions induced by antipsychotic agents (e.g., phenothiazines, thioxanthenes).a b Trihexyphenidyl Hydrochloride Dosage and Administration Administration Oral AdministrationAdminister orally before or after meals, depending on patient reaction.a b Administer before meals in patients with excessive xerostomia.a Administer after meals if nausea occurs.a May be administered 3 times daily; if a fourth dose is required, administer at bedtime.b Mint candies, chewing gum, water, or administration of a saliva substitute (e.g., Xero-lube) may relieve xerostomia that may accompany administration after meals.a b DosageAvailable as trihexyphenidyl hydrochloride; dosage expressed in terms of the salt.a Adjust dosage carefully according to individual requirements and response.b Adults Parkinsonian Syndrome OralInitially, 1 mg on first day.a Dosages may be increased in 2-mg increments at 3- to 5-day intervals up to a maximum of 6–10 mg daily.a b Postencephalitic patients: 12–15 mg daily may be required.a b When trihexylphenidyl is used as an adjunct to levodopa, consider reducing levodopa and trihexyphenidyl dosages.a Generally, 3–6 mg daily of trihexyphenidyl hydrochloride is adequate.a If trihexyphenidyl is replacing another antiparkisonian agent, increase trihexyphenidyl dose as needed while decreasing other drug dose until complete replacement is achieved.b Drug-Induced Extrapyramidal Reactions OralUsual dosage: 5–15 mg total daily dosage.a b Initially, 1 mg; if extrapyramidal reactions are not controlled within a few hours, progressively increase dosage until control is achieved. a b Alternatively, to achieve a more rapid control, reduce dosage of the drug causing the reaction, then adjust the dosage of both drugs to attain the desired drug effect without extrapyramidal symptoms.b Once control of extrapyramidal reactions has been maintained for several days, dosage of trihexyphenidyl may be reduced or discontinued.b Prescribing Limits Adults Parkinsonian Syndrome OralMaximum of 6–10 mg daily in most patients; postencephalitic patients may require 12–15 mg daily.a b Special Populations Hepatic ImpairmentNo specific dosage recommendations at this time.a Renal ImpairmentNo specific dosage recommendations at this time.a Geriatric PatientsPatients ?60 years of age: Initiate with low dosage; titrate dosage gradually.a Cautions for Trihexyphenidyl Hydrochloride ContraindicationsKnown hypersensitivity to trihexylphenidyl or any ingredient in the formulation.c Warnings/Precautions Warnings Ophthalmic EffectsPossible increased ocular tension.a Possible precipitation of glaucoma in patients receiving prolonged therapy.a c Use with caution in patients with glaucoma.a c Periodic gonioscopic evaluation and intraocular pressure monitoring recommended.a b General Precautions Tardive DyskinesiaAntiparkinsonian agents do not alleviate symptoms of tardive dyskinesia and may aggravate these symptoms.a Cardiovascular EffectsPossible tachycardia;a use with caution and carefully monitor patients with cardiac disease or hypertension.a c GU EffectsPossible urinary hesitancy and retention;a c use with caution and carefully monitor patients with prostatic hypertrophy or obstructive disease of the GU tract.a c CNS EffectsPossible mental confusion, disorientation, agitation, hallucinations, and psychotic-like symptoms.a GI EffectsPossible decreased intestinal mobility and paralytic ileus; use with caution in patients with obstructive diseases of the GI tract.a Specific Populations PregnancyCategory C.d Geriatric UsePossibility exists of greater sensitivity to the drug in some geriatric individuals.a Hepatic ImpairmentUse with caution; careful monitoring recommended.a Renal ImpairmentUse with caution; careful monitoring recommended.a Common Adverse EffectsDry mouth, blurred vision, dizziness, nausea, nervousness.a Interactions for Trihexyphenidyl Hydrochloride Specific DrugsDrug Interaction Anticholinergic agents Increased risk of adverse anticholinergic effectsc Trihexyphenidyl Hydrochloride Pharmacokinetics AbsorptionRapidly absorbed from the GI tract following oral administration.b OnsetFollowing oral adminstration, onset of action occurs within 1 hour.b Duration6–12 hours.b Elimination Elimination RouteExcreted principally in urine, probably as unchanged drug.b Stability Storage Oral Elixir20–25°C.e Do not freeze.e Tablets20–25°C.a ActionsActionsExhibits atropine-like action and exerts antispasmodic effects on parasympathetic-innervated peripheral structures, including smooth muscle.a b Exact mechanism of action in parkinsonian syndrome not understood; may result from blockade of efferent impulses and from central inhibition of cerebral motor centers.b Competitively inhibits acetylcholine or other cholinergic stimuli at autonomic effectors innervated by postganglionic nerves.c Exhibits weak mydriatic, antisialagogue, and cardiovagal blocking effects.b Advice to PatientsPotential for drug to impair mental alertness or physical coordination; use caution when driving or operating machinery until effects on individual are known.a Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs and dietary or herbal supplements, as well as concomitant illnesses.a Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.a Importance of informing patients of other important precautionary information.a (See Cautions.) PreparationsExcipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details. * available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name Trihexyphenidyl HydrochlorideRoutes Dosage Forms Strengths Brand Names Manufacturer Oral Elixir 2 mg/5 mL* Trihexyphenidyl Hydrochloride Elixir Mikart, Pharmaceutical Associates, Pharmaceutical Ventures Tablets 2 mg* Trihexyphenidyl Hydrochloride Tablets URL, Vintage, Watson, West-Ward 5 mg* Trihexyphenidyl Hydrochloride Tablets URL, Vintage, Watson, West-Ward Comparative PricingThis pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 03/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays. Trihexyphenidyl HCl 0.4MG/ML Elixir (PHARMACEUTICAL ASSOCIATES): 473/$30.99 or 1419/$79.97 Trihexyphenidyl HCl 2MG Tablets (WATSON LABS): 90/$22.99 or 180/$39.97 Trihexyphenidyl HCl 5MG Tablets (WEST-WARD): 180/$65.99 or 280/$95.97 DisclaimerThis report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use. The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care. AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions October 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814. Referencesa. Watson Laboratories Inc. trihexyphenidyl hydrochloride tablets, USP. prescribing information. Corona, CA; 2005 May. b. AHFS drug information 2006. McEvoy GK, ed. Trihexyphenidyl. Bethesda, MD: American Society of Health-System Pharmacists; 2006:1256. c. AHFS drug information 2006. McEvoy GK, ed. Antimuscarinics/Antispasmodics General Statement. Bethesda, MD: American Society of Health-System Pharmacists; 2006:1257-64]. d. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1628 e. Pharmaceutical Associates, Inc. Trihexyphenidyl HCl elixir prescribing information. Greenville, SC; 2002 May. More Trihexyphenidyl Hydrochloride resources Trihexyphenidyl Hydrochloride Side Effects (in more detail)Trihexyphenidyl Hydrochloride Use in Pregnancy & BreastfeedingDrug ImagesTrihexyphenidyl Hydrochloride Drug InteractionsTrihexyphenidyl Hydrochloride Support Group4 Reviews for Trihexyphenidyl Hydrochloride - Add your own review/rating Trihexyphenidyl MedFacts Consumer Leaflet (Wolters Kluwer) Trihexyphenidyl Prescribing Information (FDA) Artane Advanced Consumer (Micromedex) - Includes Dosage Information Artane Concise Consumer Information (Cerner Multum) Compare Trihexyphenidyl Hydrochloride with other medications Cerebral SpasticityExtrapyramidal ReactionParkinson's Disease |
![]() |
|
|||||||||||||||||||||||||||||||||||||||||
Site Map | PageMap Copyright © RX Pharmacy Drugs List. All rights reserved. |